Inventor · disambiguated record
Alexandre Charles Michel Iannello
Also filed as: IANNELLO ALEXANDRE CHARLES MICHEL
5 granted patents·6 pending applications·5 citations·filing 2019–2025
71Inventor score
Files withACTYM THERAPEUTICS INC11
Top patents by PatentIndex Score
11 records- 0189US11779612B2Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2019·Granted Oct 10, 2023·3 cites·60 claims
- 0284US12024709B2Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironmentACTYM THERAPEUTICS INC·Filed 2020·Granted Jul 2, 2024·2 cites·47 claims
- 0380US12226439B2Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2022·Granted Feb 18, 2025·0 cites·41 claims
- 0480US2025345369A1Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0579US12201653B2Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2022·Granted Jan 21, 2025·0 cites·29 claims
- 0671US12357661B2Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2020·Granted Jul 15, 2025·0 cites·37 claims
- 0761US2024293478A1Immunostimulatory bacteria for converting macrophages into a phenotype amenable to treatment, and companion diagnostic for identifying subjects for treatmentACTYM THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0858US2022154136A1Immunostimulatory bacteria delivery platforms and their use for delivery of therapeutic productsACTYM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0955US2022380720A1Immunostimulatory bacteria delivery platforms and their use for delivery of therapeutic productsACTYM THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1053US2022119824A1Immunostimulatory bacteria-based vaccines, therapeutics, and rna delivery platformsACTYM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1153US2022135980A1Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironmentACTYM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alexandre Charles Michel Iannello files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →